Regulation of blood pressure during long-term ouabain infusion in Long- Evans rats

American Journal of Hypertension

Volumn 12, Issue 4 I, 1999, Pages 423-426

  Wang, Jingli ^a   Tempini, Aldo ^a   Schnyder, Bruno ^a   Montani, Jean Pierre ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Hypertension; Long Evans rat; Ouabain; Sodium pump

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE INHIBITOR; OUABAIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; DIURESIS; DRUG BLOOD LEVEL; HYPERTENSION; KIDNEY MASS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SODIUM EXCRETION;

ANIMALS; BLOOD PRESSURE; ENZYME INHIBITORS; GLOMERULAR FILTRATION RATE; HEART RATE; INFUSIONS, INTRAVENOUS; MALE; OUABAIN; POTASSIUM; RATS; RATS, LONG-EVANS; SODIUM; TIME FACTORS;

EID: 0032947322     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00250-7     Document Type: Article

References (17)

1. 2+ stores and cell responsiveness. Am J Physiol 1993;264:C1367-C1387.
2. Hamlyn JM, Hamilton BP, Manunta P: Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis. J Hypertens 1996;14:151-167.
3. Manunta P, Rogowski AC, Hamilton BP, Hamlyn JM: Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J Hypertens 1994;12:549-560.
4. Yuan CM, Manunta P, Hamlyn JM, et al: Long-term ouabain administration produces hypertension in rats. Hypertension 1993;22:178-187.
5. Huang BS, Huang X, Harmsen E, Leenen FHH: Chronic central versus peripheral ouabain, blood pressure, and sympathetic activity in rats. Hypertension 1994;23: 1087-1090.
6. Kurashina T, Kirchner KA, Granger JP, Patel AR: Chronic sodium-potassium-ATPase inhibition with ouabain impairs renal haemodynamics and pressure natriuresis in the rat. Clin Sci 1996;91:497-502.
7. Li M, Martin A, Wen C, et al: Long-term ouabain administration does not alter blood pressure in conscious Sprague-Dawley rats. Clin Exp Pharmacol Physiol 1995;22:919-923.
8. Yasujima M, Abe K, Tanno M, et al: Effects of ouabain on blood pressure regulation in rats. J Hypertens 1986; 4:597-601.
9. +-ATPase inhibitor to cause hypertension in sodium-loaded or deoxycorticosterone-treated one kidney rats. Life Sci 1985;37:767-774.
10. Pidgeon GB, Richards AM, Nicholls MG, et al: Chronic ouabain infusion does not cause hypertension in sheep. Am J Physiol 1996;270:E386-E392.
11. Hildebrandt DA, Montani JP, Heath BJ, Granger JP: Chronic ouabain infusion alters systemic hemodynamics in normal dogs (abst). FASEB J 1995;9:A297.
12. Pidgeon GB, Richards AM, Nicholls MG, et al: Effect of ouabain on pressor responsiveness in normal man. Am J Physiol 1994;267:E642-E647.
13. Montani JP, Mizelle HL, Van Vliet BN, Adair TH: Advantages of continuous measurement of cardiac output 24 h a day. Am J Physiol 1995;269:H696-H703.
14. Riesselmann A, Baron A, Fregly MJ, van Bergen P: Hypertension during chronic exposure to cold: comparison between Sprague-Dawley and Long-Evans strains. Can J Physiol Pharmacol 1992;70:701-708.
15. el Zein M, Areas JL, Knapka J, et al: Development of sugar-induced blood pressure elevation after uninephrectomy in a resistant rat strain. J Am Coll Nutr 1991;10:24-33.
16. Holland OB, Gomez-Sanchez C, Ziegler T: Hypertension with mineralocorticoid administration to the Long-Evans rat. Clin Sci 1979;56:109-113.
17. +-ATPase. Am J Physiol 1994;266:H350-H353.